A new study from Washington University School of Medicine in St. Louis sheds light on how human gut microbes break down processed foods — especially potentially harmful chemical changes often produced during modern food manufacturing processes.

A promising replacement for the toxic and flammable greenhouse gases that are used in most refrigerators and air conditioners has been identified by researchers from the University of Cambridge.

The growing appetite for animal protein in developing countries has resulted in a smorgasbord of antibiotic consumption for livestock that has nearly tripled the occurrence of antibiotic resistance in disease-causing bacteria easily transmitted from animals to humans, according to a recent report in the journal Science.

Oxygen threatens sustainable catalysts that use hydrogen to produce electricity in fuel cells. Researchers from Bochum and Marseille have developed a way to combat this.

On a map, submarine canyons seem identical to land canyons – so much so that researchers surmised they are shaped by the same physical laws. New research reveals distinct differences for the first time.

Eight briefcase-size satellites flying in a row may be key to improving forecasts of a hurricane's wind speed — detecting whether it will make landfall as a Category 1 or a Category 5.

Patients with advanced melanoma have been able to live longer because of several newly approved targeted treatment options, including BRAF and MEK inhibitors.

A new study by chemists at the University of Arkansas shows that X-ray crystallography, the standard method for determining the structure of proteins, can provide inaccurate information about a critical set of proteins – those found in cell membranes – which in turn could be leading to poor and inefficient drug design.

Brown University researchers, surgeons from Rhode Island Hospital and private partners will develop and test a device aimed at bridging the gap in neural circuitry created by spinal cord injury, in the hope of restoring muscle control and sensation.

With improved treatments, especially the use of anti-cancer immunotherapies, more than two-thirds of all patients diagnosed with diffuse large B-cell lymphoma (DLBCL) will survive.